Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
ID: 344629Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344629

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-054.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for the Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional). This initiative aims to enhance research infrastructure in the field of aging by fostering interdisciplinary collaborations that address significant challenges in aging research. Eligible applicants include a diverse range of organizations, such as educational institutions, nonprofits, and governmental entities, with proposals required to demonstrate innovative approaches to advancing aging research. The funding amount is capped at $500,000 in direct costs annually, with applications due by December 2, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-054.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-054-Full-Announcement.html
    PAR-23-054.html
    The Department of Health and Human Services has issued a funding opportunity announcement (FOA) through the National Institutes of Health (NIH) for the Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (PAR-23-054). This initiative aims to enhance research infrastructure in the science of aging, focusing on interdisciplinary collaborations while targeting key questions within aging research. Eligible applicants include various educational institutions, nonprofits, for-profit organizations, and governmental entities. Successful proposals must demonstrate how they will develop novel infrastructures to advance aging research and contribute to the broader research community. Important dates include application deadlines beginning June 2, 2023, with awards not exceeding five years and a budget cap of $500,000 in direct costs annually. The FOA emphasizes the integration of different research disciplines and aims to address significant hurdles in aging research through collaborative frameworks. Applicants are encouraged to reach out to NIH contacts before submitting applications to ensure alignment with program priorities and funding criteria.
    Similar Opportunities
    Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies," aimed at enhancing research infrastructure to support interdisciplinary projects in aging science. This funding opportunity encourages the development of novel research partnerships and seeks applications that demonstrate significant advancements in research infrastructure, with a focus on biomedical, social, and behavioral research related to aging mechanisms. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and government entities, with a funding cap of $500,000 per year for projects lasting up to five years. Interested parties can find more information and submit applications through Grants.gov, with a submission deadline of December 2, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Infrastructure Development for Interdisciplinary Aging Studies" (R61/R33 - Clinical Trial Optional) aimed at advancing interdisciplinary research in aging. This initiative encourages applicants to develop novel research infrastructure that addresses critical questions in aging through collaborative efforts across various disciplines, including biological aging and behavioral science. The funding is structured in two phases, providing up to $500,000 annually for initial activities over two years (R61) followed by three years for expanded activities (R33), with applications accepted from eligible institutions and organizations until December 3, 2025. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-218.html.
    Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)" aimed at advancing the science of aging through innovative research infrastructure. This initiative invites applications from a diverse range of eligible institutions to develop sustainable frameworks that address critical interdisciplinary questions in aging, with a focus on areas such as machine learning applications, health disparities, and behavioral aspects of aging. The funding mechanism provides up to five years of support, including two years for initial developmental activities and up to three years for expanded activities, with an award ceiling of $500,000. Interested applicants can find more information and application guidelines at the NIH website, and must submit their proposals by December 2, 2025, to be considered for this discretionary grant opportunity.
    Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for Complex Integrated Multi-Component Projects in Aging Research, designated as a U19 Clinical Trial Optional grant. This initiative aims to support large-scale, multidisciplinary research projects that address common questions related to aging, encouraging collaboration among investigators from various institutions. The program is particularly significant as it seeks to advance scientific knowledge in aging while addressing health disparities and promoting innovative research approaches. Interested applicants, including higher education institutions, nonprofits, and government agencies, can submit proposals until September 25, 2025, with a maximum project period of five years. For further inquiries, applicants may contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-213.html.
    Facilitating T1 Translational Aging Research: Preclinical and Early Phase Human Studies (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Facilitating T1 Translational Aging Research funding opportunity, aimed at advancing new therapeutics for aging-related conditions through preclinical and early-phase human studies. This initiative focuses on two main project categories: traditional drug development and data-driven computational drug repurposing strategies, with the UG3 phase supporting planning and preliminary studies for up to two years, followed by the UH3 phase for implementation activities lasting up to three years. The funding opportunity is significant for improving health outcomes for older adults, with a total anticipated funding of $2.5 million available for up to five awards, and applications are due by January 10, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for multidisciplinary research on HIV/AIDS and aging through the R21 Exploratory/Developmental Research Grant program. This initiative invites applications that aim to enhance the understanding of the biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, with specific objectives to improve prevention, testing, treatment strategies, and management of HIV-related health issues in diverse populations, particularly older adults aged 70 and above. The grant provides funding of up to $275,000 for a two-year period, with key submission dates starting April 4, 2024, and a closing date for applications set for January 7, 2027. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), specifically through the National Institute on Aging (NIA), is offering Aging Research Dissertation Awards (R36) aimed at promoting diversity within the scientific research workforce focused on aging and health-related issues. This funding opportunity is designed for senior graduate students from underrepresented backgrounds in biomedical and behavioral sciences, supporting their dissertation research in various aging-related fields. NIH allocates approximately $768,420 annually for up to 10 awards from FY 2025 to 2027, with each award covering up to $42,500 in salary and $28,656 for additional expenses, excluding tuition. Interested applicants should note that the application process begins on January 16, 2025, with a final submission deadline of November 17, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-130.html.
    Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Multidisciplinary Studies of HIV/AIDS and Aging," inviting applications for research that explores the intersection of HIV and aging. The primary objectives of this grant are to enhance understanding of the biological, clinical, and socio-behavioral aspects of aging in individuals living with HIV, as well as to improve strategies for testing, preventing, and treating HIV and managing related health complications. This funding opportunity is significant for advancing health interventions for older adults affected by HIV, with eligible applicants including a wide range of institutions such as higher education entities, community organizations, and tribal governments. Interested parties should note that the application deadline is May 7, 2027, and can find further details and guidance by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-091.html.
    NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced the NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) to support investigator-initiated multi-site interventional clinical trials focused on aging-related research. This funding opportunity aims to foster innovative biomedical and behavioral studies that address the complexities of aging, particularly in populations with multiple chronic conditions and polypharmacy. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and tribal governments, with an emphasis on rigorous trial designs that ensure ethical considerations and participant diversity. Interested parties should note that the application deadline is January 7, 2026, and further details can be found at the provided NIH grants link, with inquiries directed to grantsinfo@nih.gov.
    Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Healthcare for Older Adults from Populations that Experience Health Disparities" under the R01 Clinical Trial Optional grant program. This initiative aims to enhance the science and implementation of healthcare research focused on older adults from populations facing health disparities, specifically targeting improvements in screening, diagnostic, and clinical care guidelines, as well as fostering shared decision-making between clinicians and patients. The research is particularly significant for addressing the unique health challenges encountered by older adults from racial and ethnic minorities and underserved communities, emphasizing innovative care solutions that consider social determinants of health. Interested applicants can find more information and apply through the NIH Grants website, with the application opening on January 5, 2025, and a close date set for January 7, 2028. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.